PMC:7445716 / 47297-47892 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T273","span":{"begin":98,"end":103},"obj":"Body_part"},{"id":"T274","span":{"begin":110,"end":119},"obj":"Body_part"},{"id":"T275","span":{"begin":130,"end":140},"obj":"Body_part"},{"id":"T276","span":{"begin":311,"end":318},"obj":"Body_part"},{"id":"T277","span":{"begin":331,"end":335},"obj":"Body_part"},{"id":"T278","span":{"begin":370,"end":375},"obj":"Body_part"},{"id":"T279","span":{"begin":407,"end":415},"obj":"Body_part"},{"id":"T280","span":{"begin":420,"end":434},"obj":"Body_part"},{"id":"T281","span":{"begin":585,"end":590},"obj":"Body_part"}],"attributes":[{"id":"A273","pred":"fma_id","subj":"T273","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A274","pred":"fma_id","subj":"T274","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A275","pred":"fma_id","subj":"T275","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A276","pred":"fma_id","subj":"T276","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A277","pred":"fma_id","subj":"T277","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A278","pred":"fma_id","subj":"T278","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A279","pred":"fma_id","subj":"T279","obj":"http://purl.org/sig/ont/fma/fma61993"},{"id":"A280","pred":"fma_id","subj":"T280","obj":"http://purl.org/sig/ont/fma/fma24138"},{"id":"A281","pred":"fma_id","subj":"T281","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T133","span":{"begin":98,"end":103},"obj":"Body_part"},{"id":"T134","span":{"begin":370,"end":375},"obj":"Body_part"},{"id":"T135","span":{"begin":407,"end":415},"obj":"Body_part"},{"id":"T136","span":{"begin":585,"end":590},"obj":"Body_part"}],"attributes":[{"id":"A133","pred":"uberon_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A134","pred":"uberon_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A135","pred":"uberon_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/UBERON_0001891"},{"id":"A136","pred":"uberon_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T490","span":{"begin":365,"end":369},"obj":"Disease"}],"attributes":[{"id":"A490","pred":"mondo_id","subj":"T490","obj":"http://purl.obolibrary.org/obo/MONDO_0020347"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T319","span":{"begin":98,"end":103},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T320","span":{"begin":110,"end":119},"obj":"http://purl.obolibrary.org/obo/CL_0000738"},{"id":"T321","span":{"begin":151,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0003622"},{"id":"T322","span":{"begin":187,"end":190},"obj":"http://purl.obolibrary.org/obo/CLO_0001417"},{"id":"T323","span":{"begin":289,"end":294},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T324","span":{"begin":331,"end":335},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T325","span":{"begin":370,"end":375},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T326","span":{"begin":370,"end":375},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T327","span":{"begin":572,"end":574},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T328","span":{"begin":585,"end":590},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T299","span":{"begin":163,"end":165},"obj":"Chemical"},{"id":"T305","span":{"begin":198,"end":206},"obj":"Chemical"},{"id":"T306","span":{"begin":311,"end":318},"obj":"Chemical"},{"id":"T307","span":{"begin":483,"end":495},"obj":"Chemical"}],"attributes":[{"id":"A299","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_16110"},{"id":"A300","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_49183"},{"id":"A301","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_53201"},{"id":"A302","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_55395"},{"id":"A303","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_57643"},{"id":"A304","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_61433"},{"id":"A305","pred":"chebi_id","subj":"T305","obj":"http://purl.obolibrary.org/obo/CHEBI_82594"},{"id":"A306","pred":"chebi_id","subj":"T306","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A307","pred":"chebi_id","subj":"T307","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PubTator","denotations":[{"id":"666","span":{"begin":217,"end":222},"obj":"Gene"},{"id":"704","span":{"begin":233,"end":243},"obj":"Gene"},{"id":"898","span":{"begin":348,"end":374},"obj":"Disease"}],"attributes":[{"id":"A666","pred":"tao:has_database_id","subj":"666","obj":"Gene:1397"},{"id":"A704","pred":"tao:has_database_id","subj":"704","obj":"Gene:2244"},{"id":"A898","pred":"tao:has_database_id","subj":"898","obj":"MESH:D001927"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-sentences","denotations":[{"id":"T250","span":{"begin":62,"end":150},"obj":"Sentence"},{"id":"T251","span":{"begin":151,"end":162},"obj":"Sentence"},{"id":"T252","span":{"begin":163,"end":197},"obj":"Sentence"},{"id":"T253","span":{"begin":198,"end":342},"obj":"Sentence"},{"id":"T254","span":{"begin":343,"end":364},"obj":"Sentence"},{"id":"T255","span":{"begin":365,"end":557},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T663","span":{"begin":351,"end":364},"obj":"Phenotype"},{"id":"T664","span":{"begin":377,"end":403},"obj":"Phenotype"}],"attributes":[{"id":"A663","pred":"hp_id","subj":"T663","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A664","pred":"hp_id","subj":"T664","obj":"http://purl.obolibrary.org/obo/HP_0032070"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T500","span":{"begin":37,"end":49},"obj":"UBERON:0001016"},{"id":"T501","span":{"begin":98,"end":103},"obj":"UBERON:0001443"},{"id":"T502","span":{"begin":130,"end":140},"obj":"CL:0000542"},{"id":"T503","span":{"begin":198,"end":206},"obj":"CHEBI:82594;CHEBI:82594"},{"id":"T504","span":{"begin":234,"end":244},"obj":"GO:0005577"},{"id":"T505","span":{"begin":283,"end":288},"obj":"NCBITaxon:10239"},{"id":"T506","span":{"begin":377,"end":391},"obj":"UBERON:0000391"},{"id":"T507","span":{"begin":407,"end":415},"obj":"UBERON:0001891"},{"id":"T508","span":{"begin":420,"end":428},"obj":"UBERON:0005434"},{"id":"T509","span":{"begin":463,"end":481},"obj":"CHEBI:5801;CHEBI:5801;DG_20"},{"id":"T510","span":{"begin":483,"end":495},"obj":"CHEBI:2955;CHEBI:2955;DG_6"},{"id":"T511","span":{"begin":585,"end":590},"obj":"UBERON:0001443"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}

{"project":"2_test","denotations":[{"id":"32840686-32532531-63205761","span":{"begin":84,"end":86},"obj":"32532531"},{"id":"32840686-32590125-63205762","span":{"begin":571,"end":573},"obj":"32590125"}],"text":"week 1 from admission no significant neurological improvement\nEsteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3. Hb 14 g/dl. PC 408,000/mm3, d-Dimer 556 ng/ml. Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count: 3x106/L Demyelinating\nAIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia\nFarzi et al. [18] RT-PCR + chest CT L"}